Section Arrow
MGRM.NASDAQ
- Monogram Orthopaedics
Quotes are at least 15-min delayed:2025/01/21 05:26 EST
Last
 2.57
+0.03 (+1.18%)
Day High 
2.64 
Prev. Close
2.54 
1-M High
2.9525 
Volume 
36.35K 
Bid
2.3
Ask
2.68
Day Low
2.4541 
Open
2.54 
1-M Low
2.3 
Market Cap 
87.15M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.49 
20-SMA 2.53 
50-SMA 2.35 
52-W High 4.9 
52-W Low 1.53 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.47/-0.24
Enterprise Value
87.52M
Balance Sheet
Book Value Per Share
0.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
365.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:26 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that canautonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.